ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,025.99
      -0.95%
      US Tech 100
      20,874.00
      -1.46%
      Dow Jones
      44,303.40
      -0.99%
      Brent Oil
      74.565
      0.00%
      Bitcoin
      96,286.07
      -0.27%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Caribou Biosciences Inc (CRBU) Quote

      Caribou Biosciences Inc

      Caribou Biosciences Inc (CRBU)

      Amd Commo Exagr
      1.35
      -0.07
      (-4.93%)
      Closed February 08 4:00PM
      Delayed by 15 minutes
      1.37
      0.02
      (1.48%)
      After Hours: 6:47PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.37
      Bid
      1.35
      Ask
      1.41
      Volume
      682,803
      1.35 Day's Range 1.42
      1.30 52 Week Range 8.33
      Market Cap
      124.057M
      Previous Close
      1.42
      Open
      1.41
      Last Trade
      800
      @
      1.37
      (formt)
      Last Trade Time
      Financial Volume
      $ 934,333
      VWAP
      1.3684
      Average Volume (3m)
      1,505,035
      Shares Outstanding
      90,552,687
      Dividend Yield
      -
      PE Ratio
      -1.20
      Earnings Per Share (EPS)
      -1.13
      Revenue
      34.48M
      Net Profit
      -102.07M

      About Caribou Biosciences Inc

      Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.cariboubio.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Caribou Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CRBU. The last closing price for Caribou Biosciences was $1.42. Over the last year, Caribou Biosciences shares have traded in a share price range of $ 1.30 to $ 8.33.

      Caribou Biosciences currently has 90,552,687 shares outstanding. The market capitalization of Caribou Biosciences is $128.58 million. Caribou Biosciences has a price to earnings ratio (PE ratio) of -1.20.

      Ask ADVFN Intelligence (AI)

      CRBU Latest News

      More News

      Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class Action - CRBU

      Investors who lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class Action - CRBU PR Newswire NEW YORK, Feb. 6, 2025 NEW YORK, Feb. 6, 2025...

      February 06 2025
      PR Newswire (US)

      Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - February 24, 2025 Deadline to Join - Contact The Gross Law Firm

      Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - February 24, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, Feb. 3, 2025 NEW YORK, Feb. 3, 2025...

      February 03 2025
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 30 2025
      Edgar (US Regulatory)

      Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

      Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025...

      January 30 2025
      PR Newswire (US)

      The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline

      The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Jan. 27, 2025 NEW YORK, Jan. 27, 2025...

      January 27 2025
      PR Newswire (US)

      The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) Shareholders

      The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) Shareholders PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025...

      January 23 2025
      PR Newswire (US)

      Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBU

      Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBU PR Newswire NEW YORK, Jan. 20, 2025 NEW YORK , Jan. 20, 2025...

      January 20 2025
      PR Newswire (US)

      CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

      CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan. 16, 2025...

      January 16 2025
      PR Newswire (US)

      Form 8-K - Current report

      January 13 2025
      Edgar (US Regulatory)

      Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

      Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025...

      January 13 2025
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.01-0.7246376811591.381.571.3216042441.41853323CS
      4-0.3-17.96407185631.671.711.315906961.47349988CS
      12-0.69-33.49514563112.062.511.315050351.76960215CS
      26-0.66-32.51231527092.032.99951.312757981.93830232CS
      52-5.52-80.11611030486.898.331.316639432.90971239CS
      156-9.32-87.184284377910.6913.191.313445745.05427123CS
      260-16.28-92.237960339917.6532.6451.312366276.28785974CS

      CRBU - Frequently Asked Questions (FAQ)

      What is the current Caribou Biosciences share price?
      The current share price of Caribou Biosciences is $ 1.37
      How many Caribou Biosciences shares are in issue?
      Caribou Biosciences has 90,552,687 shares in issue
      What is the market cap of Caribou Biosciences?
      The market capitalisation of Caribou Biosciences is USD 128.58M
      What is the 1 year trading range for Caribou Biosciences share price?
      Caribou Biosciences has traded in the range of $ 1.30 to $ 8.33 during the past year
      What is the PE ratio of Caribou Biosciences?
      The price to earnings ratio of Caribou Biosciences is -1.2
      What is the cash to sales ratio of Caribou Biosciences?
      The cash to sales ratio of Caribou Biosciences is 3.55
      What is the reporting currency for Caribou Biosciences?
      Caribou Biosciences reports financial results in USD
      What is the latest annual turnover for Caribou Biosciences?
      The latest annual turnover of Caribou Biosciences is USD 34.48M
      What is the latest annual profit for Caribou Biosciences?
      The latest annual profit of Caribou Biosciences is USD -102.07M
      What is the registered address of Caribou Biosciences?
      The registered address for Caribou Biosciences is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
      What is the Caribou Biosciences website address?
      The website address for Caribou Biosciences is www.cariboubio.com
      Which industry sector does Caribou Biosciences operate in?
      Caribou Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MGOLMGO Global Inc
      $ 0.4191
      (126.54%)
      		816.59M
      CDTConduit Pharmaceuticals Inc
      $ 2.831
      (82.65%)
      		144.17M
      GSIWGarden Stage Ltd
      $ 0.79
      (78.73%)
      		219.64M
      TOIIWOncology Institute Inc
      $ 0.033
      (58.88%)
      		7.27k
      CYTHCyclo Therapeutics Inc
      $ 1.19
      (54.55%)
      		84.73M
      FTELFitell Corporation
      $ 2.70
      (-57.01%)
      		2.3M
      SGBXSafe and Green Holdings Corporation
      $ 0.6401
      (-44.82%)
      		5.65M
      NKLANikola Corporation
      $ 0.4432
      (-41.10%)
      		52.44M
      PLRXPliant Therapeutics Inc
      $ 7.785
      (-34.85%)
      		6.44M
      LIPOLipella Pharmaceuticals Inc
      $ 3.08
      (-33.76%)
      		2.2M
      MGOLMGO Global Inc
      $ 0.4191
      (126.54%)
      		816.59M
      RIMEAlgorhythm Holdings Inc
      $ 0.0169
      (-20.66%)
      		274.2M
      NVDANVIDIA Corporation
      $ 129.84
      (0.90%)
      		228.2M
      GSIWGarden Stage Ltd
      $ 0.79
      (78.73%)
      		219.64M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0537
      (14.74%)
      		212.29M

      CRBU Discussion

      View Posts
      theorysuit theorysuit 1 week ago
      What do you think of their shift to partial HLA matching?
      👍️0
      Monksdream Monksdream 1 month ago
      CRBU. Under $2
      👍️0
      Monksdream Monksdream 2 months ago
      CRBU under $2
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      CRBU READY TO BEAST
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      CRBU...NEW SCAN JUST GAVE ME THIS BIO
      👍️0
      Monksdream Monksdream 4 months ago
      CRBU under $3
      👍️0
      Monksdream Monksdream 4 months ago
      CRBU under $2
      👍️0
      Monksdream Monksdream 5 months ago
      CRBU under $3
      👍️0
      Monksdream Monksdream 6 months ago
      CRBU under $3
      👍️0
      jondoeuk jondoeuk 7 months ago
      Earlier this year development of the lead CAR-NK programme, CB-020, was stopped, and now they are out of CAR-NK altogether. They disclosed it in an SEC filing and outlined a 12% workforce reduction https://www.sec.gov/Archives/edgar/data/1619856/000161985624000054/crbu-20240716.htm

      This should extend their cash runway by at least six months, into the second half of 2026.
      👍️0
      Monksdream Monksdream 7 months ago
      CRBU under $3
      👍️0
      Monksdream Monksdream 7 months ago
      CRBU new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      CRBU new 52 week low
      👍️0
      NY1972 NY1972 8 months ago
      Without engaging macrophage long term, CART and other ACT will have persistence issue as regulatory lymphocytes and TAM recoup. AFMD has the best approach with ICE engaging a few B CBNK cells for start and engaging endogenous NK and M in the maintenance phase
      👍️0
      Diego Rivas Diego Rivas 8 months ago
      Any good news in here comming?
      👍️0
      jondoeuk jondoeuk 8 months ago
      Among patients with four or more matching HLA alleles, mPFS was 14.4 months, versus 2.8 months in patients with three or fewer matches. But this is based on a retrospective analysis, so they will need to prove the theory prospectively. It was better in LBCL, with mPFS not reached, versus 2.8 months. Also, some improvement in the now-selected dose, 80 million CAR-T cells.
      👍️0
      jondoeuk jondoeuk 8 months ago
      The BCMA-targeted space is already crowded enough and off-target toxicities, including agranulocytosis* could be a problem for its anti-CLL-1 CAR.

      * CLL-1 is also highly expressed on almost all granulocytes and monocytes and on parts of myeloid progenitors in the normal bone marrow and peripheral blood.
      👍️0
      Monksdream Monksdream 8 months ago
      CRBU new 52 week low
      👍️0
      stocksrising stocksrising 8 months ago
      Yep, not a positive trend hence sub $3’s…fortunately other trials for varied indications could save company…
      👍️0
      jondoeuk jondoeuk 8 months ago
      It gets worse. The updated (CB-010) data shows that the ORR (including CR rate) has fallen, so has the mDOR, the six-month PFS is poor and the pivotal trial has been delayed until H2 2025 following a new HLA partial matching strategy. The latter completely alters (in a bad way) the commercial strategy for an allo CAR-T product. They now need thirteen different off-the-shelf batches to be able to cater to ~90% of patients based on an ideal HLA match.
      👍️ 1
      Monksdream Monksdream 9 months ago
      CRBU new 52 week low
      👍️0
      Monksdream Monksdream 9 months ago
      CRBU new 52 week low
      👍️0
      Monksdream Monksdream 9 months ago
      CRBU under $5
      👍️0
      stocksrising stocksrising 11 months ago
      It seemed like they were running on all positive cylinders, but must have blown a gasket at current Conference/ Fireside???
      👍️0
      Monksdream Monksdream 1 year ago
      CRBU new 52 week low
      👍️0
      jondoeuk jondoeuk 2 years ago
      Yes, with both drugs still in development. As for CRBU, they gave an update (plus public offering) https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html https://investor.cariboubio.com/static-files/d818ed1a-aea2-41c1-84ea-bd05a4276cbb

      Personally, there seem to be red flags, such as no expansion/persistence data. I know they give huge amounts of LD chemo, higher (I think) than anyone else, which could be generating responses, explaining why there is no dose response.
      👍️0
      trueblue trueblue 2 years ago
      .
      👍️0
      trueblue trueblue 2 years ago
      $23.00 price target! Now that is a good start!! Glad I loaded up! Jmo
      👍️0
      NY1972 NY1972 2 years ago
      Didn't they buy TRIL? Just gambling with billions from US government.
      👍️0
      jondoeuk jondoeuk 2 years ago
      PFE is very selective in who they fund https://finance.yahoo.com/news/caribou-biosciences-announces-25-million-120000433.html
      👍️0
      trueblue trueblue 2 years ago
      Great day in my accounts again! Really liking my CRBU shares! Jmo holding for the long haul!!
      👍️0
      Monksdream Monksdream 2 years ago
      CRBU now No 9 on the Barchart Top 10
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      trueblue trueblue 2 years ago
      Added to my existing shares today, I bought shares months ago. I like Crbu a crisper company! Looks like Pfizer does also! Jmo
      👍️0
      Stockexpertpro Stockexpertpro 2 years ago
      CRBU Loss 108 Million Dollars Company only has preclinical and phase 1 in its pipeline company is Years away from having anything if ever did a stock offering at 5.33$ for 25 Million thats only 1 QTR Cash burn for this company Sell the News https://www.cariboubio.com/pipeline/
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      CRBU= JUST WOW

      https://finviz.com/quote.ashx?t=CRBU&ty=c&ta=1&p=d
      👍️0
      Monksdream Monksdream 2 years ago
      CRBU No 1 on the early Barchart Top 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0

      Your Recent History

      NASDAQ
      CRBU
      Caribou Biosciences
      EU
      AVTX
      Avantium NV
      TG
      A3LQZS
      Nestle
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads